← Back to Analyst Consensus 
APYX Buy
Apyx Medical Corp
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | Maxim Group | initiate | — → Buy | — | 42% |
| Jul 13, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Mar 11, 2026 | Craig-Hallum | maintain | Buy → Buy | — | 54% |
| Mar 11, 2026 | BTIG | upgrade | Neutral → Buy | — | 52% |
| Dec 16, 2025 | Roth Capital | initiate | — → Buy | $6 | 53% |
| Nov 12, 2025 | Citizens | upgrade | Market Perform → Market Outperform | $8 | 46% |
| Oct 17, 2024 | BTIG | initiate | — → Neutral | $0 | 52% |
| Sep 16, 2024 | JMP Securities | reiterate | — → Market Perform | $0 | 53% |
| Nov 10, 2023 | Stephens & Co. | maintain | Overweight → Overweight | $5 | 54% |
| Aug 11, 2023 | Piper Sandler | maintain | Overweight → Overweight | $4.5 | 54% |
| Jul 14, 2023 | Stephens & Co. | initiate | — → Overweight | $8 | 54% |
| Jun 15, 2023 | Lake Street | maintain | — → Buy | $9 | 47% |
| May 24, 2023 | JMP Securities | reiterate | — → Market Perform | $0 | 53% |
| May 12, 2023 | Lake Street | maintain | Buy → Buy | $6 | 47% |
| Aug 12, 2022 | Piper Sandler | maintain | — → Overweight | $12 | 54% |
| Jul 19, 2022 | Lake Street | maintain | — → Buy | $17 | 47% |
| May 20, 2022 | Lake Street | initiate | — → Buy | $12 | 47% |
| Aug 13, 2021 | JMP Securities | maintain | — → Market Outperform | $14 | 53% |
| May 12, 2020 | JMP Securities | maintain | — → Market Outperform | $5 | 53% |
| Nov 12, 2019 | Piper Sandler | maintain | — → Overweight | $10 | 54% |
| Apr 2, 2019 | JMP Securities | maintain | Market Outperform → Market Outperform | $8 | 53% |
Price Target Trend
Apr 20, 2026 Latest: $6.5 Oct 25, 2026
EPS Estimates
0q $-0.09
Lo: $-0.13 Hi: $-0.07
6 analysts ▲4
+1q $-0.05
Lo: $-0.07 Hi: $-0.02
6 analysts +1y $-0.25
Lo: $-0.32 Hi: $-0.21
6 analysts ▲3
0y $-0.27
Lo: $-0.31 Hi: $-0.23
6 analysts ▲4
Cross-Platform Signals
No cross-platform signals in the last 90 days